global messaging alerts


Compared to more traditional sterile liquid fill-finish formats, the ApiJect Platform has designed simplicity and reliability into its material procurement and production supply chain.

Simplified Material Procurement

Blow-Fill-Seal (BFS) and prefilled injection systems designed on the ApiJect Platform require only two primary materials to be procured: pharmaceutical-grade resins (LDPE and PP) and cannula.

  • Both materials can typically be sourced in all major markets and reliably produced in sufficient scale.
  • Needles and resin potentially can be stockpiled at the manufacturing facilities, ensuring localized supply.
  • Made of low-density polyethylene, BFS containers have very limited delamination issues.
  • Materials used in the secondary packaging process, such as a drug label, foil pouch, and boxing, are generally also available in all major markets.

Highly Compact End-to-End Supply Chain

  • Once a mold is installed and the line is qualified, a BFS machine can scale-up reliably and quickly.
  • Needle hub manufacturing for Prefilled ApiJect Injectors* is done by Tae-Change Industrial™ of South Korea, the world’s second largest cannula supplier by volume.
  • A BFS filling line only requires approx. 500 sq. ft. of ISO-7 space.
  • ApiJect pre-set modular manufacturing units fulfills response for local, regional and international sterile manufacturing needs.
  • BFS containers are resistant to breakage or shattering, making them a very robust option for distribution and warehousing in all markets.
  • Kitting of the BFS containers and attachable components can be done in the same facility as the BFS manufacturing (today it is done in a separate facility).

*The Prefilled ApiJect Injector and its components are not cleared by the FDA or other regulatory bodies.

To learn more about the ApiJect Platform’s supply chain, contact Sr. Director of Supply Chain, Josh Myers.

random footer image
Social media & sharing icons powered by UltimatelySocial